Jason Celian, Chief Accounting Officer of Versigent PLC (NYSE:VGNT), filed a Form 4 on September 22, 2026, disclosing the acquisition of 25.753 dividend equivalent rights on September 18, 2026, accrued on existing restricted stock unit grants.
Director Kevin P. Clark filed a Form 4 with the SEC on September 22, 2026, reporting the acquisition of dividend equivalent rights tied to restricted stock units in Versigent PLC, with the earliest transaction dated September 18, 2026.
Director Amy E. Alving filed a Form 4 with the SEC on September 22, 2026, disclosing the acquisition of dividend equivalent rights tied to restricted stock units in Versigent PLC (NYSE:VGNT), with the transaction dated September 18, 2026.
A Form 4 filed with the SEC on September 22, 2026 discloses that Theoharrys Evgenios Kosmatos, CFO and CAO of Tsakos Energy Navigation Ltd (NYSE:TEN), sold 10,000 common shares on September 18, 2026.
A Form 4 filed on September 22, 2026, reports that Alberto Perez Jacome Friscione, a director of Rocky Mountain Chocolate Factory, Inc. (NASDAQ:RMCF), acquired 7,000 shares of common stock at no cost as a board committee participation grant.
Director Melvin L. Keating filed a Form 4 with the SEC on September 22, 2026, disclosing an acquisition of common stock in Rocky Mountain Chocolate Factory, Inc. (NASDAQ:RMCF).
Director Brian J. Quinn of Rocky Mountain Chocolate Factory, Inc. filed a Form 4 on September 22, 2026, reporting the acquisition of 7,000 shares of common stock at no cost as a Board of Directors committee participation grant.
A Form 4 filed on September 22, 2026 reports that Ralph Alvarez, a director of Eli Lilly & Co (NYSE:LLY), acquired 10.6591 shares of common stock on September 21, 2026 through the company's Directors' Deferral Plan in lieu of cash compensation.
A Form 4 filed on September 22, 2026 reports that J. Erik Fyrwald, a director of Eli Lilly & Co (NYSE:LLY), acquired 8.513 shares of common stock on September 21, 2026 under the company's Directors' Deferral Plan.
A Form 4 filed with the SEC on September 22, 2026 discloses that Juan R. Luciano, a director of Eli Lilly & Co (NYSE:LLY), acquired 13.6637 shares of common stock on September 21, 2026 under the company's Directors' Deferral Plan.